HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Luis Felipe Campesato Selected Research
Luis Felipe Campesato Research Topics
Disease
10
Neoplasms (Cancer)
01/2024 - 11/2016
2
Melanoma (Melanoma, Malignant)
01/2024 - 12/2021
1
Carcinoma (Carcinomatosis)
11/2021
1
Experimental Melanoma
11/2021
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1
Adenocarcinoma
01/2020
1
Breast Neoplasms (Breast Cancer)
07/2017
Drug/Important Bio-Agent (IBA)
2
eprenetapopt
IBA
01/2024 - 01/2022
2
Immune Checkpoint Inhibitors
IBA
11/2021 - 11/2020
1
Vaccines
IBA
01/2024
1
Immunomodulating Agents
IBA
01/2024
1
pembrolizumab
IBA
01/2022
1
Phosphatidylserines
IBA
12/2021
1
Protein Isoforms (Isoforms)
IBA
11/2021
1
Enzymes
IBA
11/2020
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
11/2020
1
Tryptophan (L-Tryptophan)
FDA Link
11/2020
1
Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)
IBA
11/2020
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2020
1
Cytokines
IBA
01/2020
1
Conditioned Culture Media
IBA
01/2020
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
01/2020
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2019
1
Therapeutic Uses
IBA
01/2019
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
07/2017
1
Programmed Cell Death 1 Receptor
IBA
11/2016
1
Antibodies
IBA
11/2016
1
Proteins (Proteins, Gene)
FDA Link
11/2016
1
B7-H1 Antigen
IBA
11/2016
Therapy/Procedure
4
Immunotherapy
11/2020 - 11/2016
3
Therapeutics
11/2021 - 07/2017
2
Radiotherapy
12/2021 - 01/2020
1
Drug Therapy (Chemotherapy)
01/2020